Biomea Fusion Inc (BMEA) USD0.0001

Sell:$1.94Buy:$1.95Price increased$0.05 (2.39%)

NASDAQ:Price increased1.96%
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.94
Buy:$1.95
Change:Price increased$0.05 (2.39%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.94
Buy:$1.95
Change:Price increased$0.05 (2.39%)
Market closed |
Prices delayed by at least 15 minutes

Key metrics

Open$1.91
Previous close$1.88
Market cap$135.20m
P/E ratio-99999.99
Volume350,384
Dividend yield0.00%
EMS-

Biomea Fusion, Inc. is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small molecules to improve the lives of patients with diabetes, obesity, and ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue72.30m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.